To conclude, in this study we report the frequency of EGFR mutations in a cohort of 956 lung cancer patients as well as the frequency of alterations in KRAS, BRAF, MET, PIK3CA and ALK genes in a subset of these patients. This evidence concerns the gene EGFR and lung carcinoma.